Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.433
-0.051 (-10.58%)
At close: Jan 31, 2025, 4:00 PM
0.463
+0.030 (6.91%)
After-hours: Jan 31, 2025, 5:54 PM EST
Turnstone Biologics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Jan '25 Jan 31, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 10 | 59 | - | - |
| Enterprise Value | -34 | -47 | - | - |
| Last Close Price | 0.43 | 2.54 | - | - |
| PS Ratio | - | 3.04 | - | - |
| PB Ratio | 0.23 | 0.60 | - | - |
| P/TBV Ratio | 0.30 | 0.60 | - | - |
| Debt / Equity Ratio | 0.04 | 0.03 | 0.07 | 0.03 |
| Debt / EBITDA Ratio | - | - | - | 0.07 |
| Asset Turnover | - | 0.17 | 0.49 | - |
| Quick Ratio | 3.32 | 7.93 | 2.61 | 3.05 |
| Current Ratio | 3.75 | 8.57 | 2.81 | 3.23 |
| Return on Equity (ROE) | -94.47% | -65.27% | -38.45% | - |
| Return on Assets (ROA) | -50.75% | -32.34% | -10.18% | - |
| Return on Capital (ROIC) | -59.13% | -41.49% | -18.28% | - |
| Earnings Yield | -743.41% | -93.92% | - | - |
| FCF Yield | -666.47% | -114.68% | - | - |
| Buyback Yield / Dilution | -256.36% | -365.39% | 7.96% | - |
| Total Shareholder Return | -256.36% | -365.39% | 7.96% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.